Adjuvant chemoradiotherapy with gemcitabine and cisplatin and postoperative radiotherapy (PORT) versus PORT alone in high risk bladder cancer patients. A phase III randomized controlled trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback